会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明授权
    • Lactam ring-opening enzyme and use thereof
    • 内酰胺开环酶及其用途
    • US07892784B2
    • 2011-02-22
    • US11710612
    • 2007-02-26
    • Hiroshi TakagiYoshimitsu Hamano
    • Hiroshi TakagiYoshimitsu Hamano
    • C12P1/00C12P17/00C12P17/16C12P15/00
    • C12N9/86C12P19/28
    • An enzyme capable of reducing the antibiotic activity (i.e., toxicity) of streptothricin with respect to eukaryotic cells without sacrificing antibiotic activity with respect to prokaryotic cells is provided along with a streptothricin derivative having reduced toxicity with respect to eukaryotic cells while retaining antibiotic activity with respect to prokaryotic cells, and a manufacturing method thereof. By opening the lactam ring of streptothricin, a protein having the amino acid sequence according to SEQ ID NO: 2, 4, 6, 8, 10, 12, 14 or 16 of the invention can reduce the antibiotic activity of streptothricin D with respect to eukaryotic cells without sacrificing antibiotic activity with respect to prokaryotic cells.
    • 提供能够降低链霉素相对于真核细胞的抗生素活性(即毒性)而不牺牲相对于原核细胞的抗生素活性的酶以及相对于真核细胞毒性降低的链球菌素衍生物,同时保持抗生素活性 原核细胞及其制造方法。 通过打开链霉素的内酰胺环,具有根据本发明的SEQ ID NO:2,4,6,8,10,12,14或16的氨基酸序列的蛋白质可以降低链球菌D的抗生素活性,相对于 真核细胞,而不牺牲相对于原核细胞的抗生素活性。